TeraCyte Analytics
Rick Borenstein is an accomplished executive with extensive experience in technology investing and board leadership. Currently serving as a Board Member at TeraCyte Analytics and a Venture Partner at PeakBridge VC, Borenstein contributes to high-impact FoodTech investment strategies. Borenstein holds positions on the Board of Directors for Tastewise.io and NYM Health, with previous roles as Chairman of the Board for Buddy Technologies Limited and Buddy Platform Ltd. Notably, Borenstein led Buddy Platform to a successful public offering on the ASX. Borenstein’s career at Sequoia Partners Inc. spans over three decades, during which more than 250 transactions were successfully completed. Borenstein earned an MBA in Finance from Harvard Business School and holds an AB in Economics from the University of Michigan.
This person is not in any teams
TeraCyte Analytics
Our breakthrough Array Cytometry (TM) technology introduces large-scale acquisition of dynamic single-cell responses. TeraCyte’s world-renowned team of system biologists, computational biologists and data experts will use this dynamic data to build predictive models and applications and streamline drug development.